Aptevo Therapeutics Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Aptevo Therapeutics Inc. (APVO), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Are APVO insiders buying or selling?
In the last 12 months, Aptevo Therapeutics Inc. insiders reported 1 open-market purchase ($20.1K) and 0 sales ($0) — net buying of $20.1K. Since March 2018, Trabud has recorded 28 Form 4 filings for APVO: 26 buys ($25.9M) and 2 sells ($16.9M).
Source: SEC EDGAR Form 4
What stands out
- The largest open-market purchase in the last 12 months was $20.1K by Grady Grant III (Director) on Nov 12, 2025. SEC ↗
- The most recent open-market purchase was reported on Nov 12, 2025 (11 months ago).
Key Statistics (March 2018 – Nov 12, 2025)
Total Form 4 filings
28
SEC EDGAR
Insider filers
9
Insider buys (26)
$25.9M
Insider sells (2)
$16.9M
Insider sentiment
Net buyingNet insider flow of $9.1M in net buying since March 2018, and $20.1K in net buying over the last 12 months.
Recent APVO insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 12, 2025 | Grady Grant III | Director | Purchase | 13.5K | $1.49 | $20.1K | SEC ↗ |
| Jun 3, 2022 | John Niederhuber | Director | Purchase | 714 | $0.91 | $649.74 | SEC ↗ |
| Nov 26, 2021 | Kevin C Tang | Other | Sale | 921.3K | $11.25 | $10.4M | SEC ↗ |
| Nov 22, 2021 | Kevin C Tang | 10% Owner | Sale | 838.7K | $7.75 | $6.5M | SEC ↗ |
| Nov 6, 2020 | TANG KEVIN C | 10% Owner | Purchase | 1.4M | $17.30 | $24.8M | SEC ↗ |
| Aug 19, 2019 | Randy Joe Maddux | SVP Operations, CMO | Purchase | 25.0K | $0.76 | $19.0K | SEC ↗ |
| Aug 14, 2019 | Fuad El-Hibri | Director | Purchase | 100.0K | $0.76 | $75.5K | SEC ↗ |
| Jul 30, 2019 | Fuad El-Hibri | Board of Directors | Purchase | 55.0K | $0.83 | $45.9K | SEC ↗ |
| Jul 24, 2019 | Fuad El-Hibri | Board of Directors | Purchase | 10.0K | $0.90 | $9.0K | SEC ↗ |
| Jul 23, 2019 | Fuad El-Hibri | Board of Directors | Purchase | 30.0K | $0.89 | $26.6K | SEC ↗ |
| Jul 19, 2019 | Fuad El-Hibri | Board of Directors | Purchase | 26.5K | $0.90 | $23.7K | SEC ↗ |
| Jul 18, 2019 | Fuad El-Hibri | Board of Directors | Purchase | 14.4K | $0.87 | $12.6K | SEC ↗ |
| Jul 18, 2019 | Fuad El-Hibri | Board of Directors | Purchase | 19.1K | $0.87 | $16.7K | SEC ↗ |
| Jul 16, 2019 | Fuad El-Hibri | Board of Directors | Purchase | 11.4K | $0.85 | $9.7K | SEC ↗ |
| Jul 12, 2019 | Fuad El-Hibri | Board of Directors | Purchase | 14.7K | $0.85 | $12.5K | SEC ↗ |
| Jul 11, 2019 | Fuad El-Hibri | Director | Purchase | 18.9K | $0.85 | $16.1K | SEC ↗ |
| Jun 25, 2019 | Daniel Abdun-Nabi | Board of Directors | Purchase | 16.7K | $0.90 | $15.0K | SEC ↗ |
| Jun 14, 2019 | Marvin L White | President and CEO | Purchase | 50.0K | $0.88 | $44.0K | SEC ↗ |
| Jun 11, 2019 | Barbara Lopez Kunz | Board of Directors | Purchase | 10.0K | $0.85 | $8.5K | SEC ↗ |
| Jun 7, 2019 | Zsolt Harsanyi | Board of Directors | Purchase | 50.0K | $0.78 | $39.0K | SEC ↗ |
| Jun 7, 2019 | Randy Joe Maddux | Senior VP, Operations | Purchase | 20.0K | $0.73 | $14.6K | SEC ↗ |
| May 21, 2019 | Grady Grant III | Board of Directors | Purchase | 10.0K | $0.80 | $8.0K | SEC ↗ |
| May 20, 2019 | Marvin L White | President and CEO | Purchase | 30.0K | $0.81 | $24.3K | SEC ↗ |
| May 15, 2019 | Marvin L White | President and CEO | Purchase | 10.0K | $0.78 | $7.8K | SEC ↗ |
| Dec 7, 2018 | Randy Joe Maddux | SVP Operations | Purchase | 5.0K | $2.37 | $11.8K | SEC ↗ |
Showing the 25 most recent of 28 Form 4 filings for Aptevo Therapeutics Inc..
Most active APVO insiders
- Fuad El-Hibri10 filings
- Marvin L White6 filings
- Kevin C Tang3 filings
- Randy Joe Maddux3 filings
- Grady Grant III2 filings
Ask anything about APVO insider activity
Use Trabud's AI agent to query Aptevo Therapeutics Inc.'s Form 4 history in plain English — "Show me APVO CEO purchases this year" or compare it against any other ticker.
Open the AI agentAPVO insider trading FAQ
Are Aptevo Therapeutics Inc. insiders buying or selling?
In the last 12 months, Aptevo Therapeutics Inc. insiders reported 1 open-market purchase ($20.1K) and 0 sales ($0) — net buying of $20.1K. Since March 2018, Trabud has recorded 28 Form 4 filings for APVO: 26 buys ($25.9M) and 2 sells ($16.9M). Over the full record that is net buying of $9.1M.
How many insiders trade APVO stock?
9 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Aptevo Therapeutics Inc.. The most recent filing was accepted on Nov 12, 2025.
Where does Trabud get APVO insider trading data?
All APVO insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.